Literature DB >> 22294696

Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Christophe Paget1, Stoyan Ivanov, Josette Fontaine, Joelle Renneson, Fany Blanc, Muriel Pichavant, Laure Dumoutier, Bernhard Ryffel, Jean Christophe Renauld, Philippe Gosset, Pierre Gosset, Mustapha Si-Tahar, Christelle Faveeuw, François Trottein.   

Abstract

Invariant natural killer T (iNKT) cells are non-conventional lipid-reactive αβ T lymphocytes that play a key role in host responses during viral infections, in particular through the swift production of cytokines. Their beneficial role during experimental influenza A virus (IAV) infection has recently been proposed, although the mechanisms involved remain elusive. Here we show that during in vivo IAV infection, mouse pulmonary iNKT cells produce IFN-γ and IL-22, a Th17-related cytokine critical in mucosal immunity. Although permissive to viral replication, IL-22 production by iNKT cells is not due to IAV infection per se of these cells but is indirectly mediated by IAV-infected dendritic cells (DCs). We show that activation of the viral RNA sensors TLR7 and RIG-I in DCs is important for triggering IL-22 secretion by iNKT cells, whereas the NOD-like receptors NOD2 and NLRP3 are dispensable. Invariant NKT cells respond to IL-1β and IL-23 provided by infected DCs independently of the CD1d molecule to release IL-22. In vitro, IL-22 protects IAV-infected airway epithelial cells against mortality but has no role on viral replication. Finally, during early IAV infection, IL-22 plays a positive role in the control of lung epithelial damages. Overall, IAV infection of DCs activates iNKT cells, providing a rapid source of IL-22 that might be beneficial to preserve the lung epithelium integrity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22294696      PMCID: PMC3308738          DOI: 10.1074/jbc.M111.304758

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  96 in total

1.  Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection.

Authors:  Wai Ling Kok; Laura Denney; Kambez Benam; Suzanne Cole; Colin Clelland; Andrew J McMichael; Ling-Pei Ho
Journal:  J Leukoc Biol       Date:  2011-10-14       Impact factor: 4.962

2.  Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.

Authors:  Christophe Paget; Stoyan Ivanov; Josette Fontaine; Fany Blanc; Muriel Pichavant; Joelle Renneson; Emilie Bialecki; Julien Pothlichet; Catherine Vendeville; Giovanna Barba-Spaeth; Giovanna Barba-Speath; Michel-René Huerre; Christelle Faveeuw; Mustapha Si-Tahar; François Trottein
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

Review 3.  The unique role of natural killer T cells in the response to microorganisms.

Authors:  Emmanuel Tupin; Yuki Kinjo; Mitchell Kronenberg
Journal:  Nat Rev Microbiol       Date:  2007-05-08       Impact factor: 60.633

4.  Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population.

Authors:  Jonathan M Coquet; Sumone Chakravarti; Konstantinos Kyparissoudis; Finlay W McNab; Lauren A Pitt; Brent S McKenzie; Stuart P Berzins; Mark J Smyth; Dale I Godfrey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-06       Impact factor: 11.205

Review 5.  The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling.

Authors:  Hergen Spits; James P Di Santo
Journal:  Nat Immunol       Date:  2010-11-28       Impact factor: 25.606

6.  NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner.

Authors:  Julien Diana; Thibault Griseri; Sylvie Lagaye; Lucie Beaudoin; Elodie Autrusseau; Anne-Sophie Gautron; Céline Tomkiewicz; André Herbelin; Robert Barouki; Matthias von Herrath; Marc Dalod; Agnès Lehuen
Journal:  Immunity       Date:  2009-02-12       Impact factor: 31.745

7.  Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals.

Authors:  Bruno Martin; Keiji Hirota; Daniel J Cua; Brigitta Stockinger; Marc Veldhoen
Journal:  Immunity       Date:  2009-08-13       Impact factor: 31.745

8.  Aging promotes neutrophil-induced mortality by augmenting IL-17 production during viral infection.

Authors:  Heather W Stout-Delgado; Wei Du; Anushree C Shirali; Carmen J Booth; Daniel R Goldstein
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

9.  Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.

Authors:  Yan Zheng; Patricia A Valdez; Dimitry M Danilenko; Yan Hu; Susan M Sa; Qian Gong; Alexander R Abbas; Zora Modrusan; Nico Ghilardi; Frederic J de Sauvage; Wenjun Ouyang
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

10.  Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.

Authors:  Ronan Le Goffic; Viviane Balloy; Micheline Lagranderie; Lena Alexopoulou; Nicolas Escriou; Richard Flavell; Michel Chignard; Mustapha Si-Tahar
Journal:  PLoS Pathog       Date:  2006-06-09       Impact factor: 6.823

View more
  94 in total

Review 1.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

Review 2.  Cytokine crowdsourcing: multicellular production of TH17-associated cytokines.

Authors:  Kathleen O Busman-Sahay; Travis Walrath; Samuel Huber; William O'Connor
Journal:  J Leukoc Biol       Date:  2014-12-29       Impact factor: 4.962

3.  Influenza Casts a Lung Shadow.

Authors:  Xavier De Luna; Kevan L Hartshorn
Journal:  Am J Pathol       Date:  2017-02-21       Impact factor: 4.307

4.  Targeting IL22: a potential therapeutic approach for Kras mutant lung cancer?

Authors:  Frank D Weinberg; Nithya Ramnath
Journal:  Transl Lung Cancer Res       Date:  2018-09

Review 5.  Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions.

Authors:  Patrick J Brennan; Manfred Brigl; Michael B Brenner
Journal:  Nat Rev Immunol       Date:  2013-01-21       Impact factor: 53.106

Review 6.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

7.  IL-22 is essential for lung epithelial repair following influenza infection.

Authors:  Derek A Pociask; Erich V Scheller; Sivanarayana Mandalapu; Kevin J McHugh; Richard I Enelow; Cheryl L Fattman; Jay K Kolls; John F Alcorn
Journal:  Am J Pathol       Date:  2013-03-11       Impact factor: 4.307

8.  Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.

Authors:  Amanda B Macedo; Camille L Novis; Caroline M De Assis; Eric S Sorensen; Paula Moszczynski; Szu-Han Huang; Yanqin Ren; Adam M Spivak; R Brad Jones; Vicente Planelles; Alberto Bosque
Journal:  JCI Insight       Date:  2018-10-04

Review 9.  Host defenses against bacterial lower respiratory tract infection.

Authors:  Taylor Eddens; Jay K Kolls
Journal:  Curr Opin Immunol       Date:  2012-07-25       Impact factor: 7.486

Review 10.  IL-22 in tissue-protective therapy.

Authors:  Heiko Mühl; Patrick Scheiermann; Malte Bachmann; Lorena Härdle; Anika Heinrichs; Josef Pfeilschifter
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.